SC dismisses Sun Pharma's plea against NPPA's demand notice of Rs 4.65 cr for overcharging drug

The Supreme Court dismissed Sun Pharma's plea against a demand notice of Rs 4.65 crore by NPPA for overcharging for the drug Roscilox, upholding the Delhi High Court's decision. Sun Pharma challenged the demand for overcharged amount under DPCO, with the court finding no merit in the appeal. It noted Sun Pharma's direct purchase from the manufacturer and overlapping identities with Oscar Laboratories Pvt. Ltd.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KNJj1cU
via IFTTT